Windward Bio Debuts on Nasdaq with 68% Share Surge After $225 Million IPO
Trendline

Windward Bio Debuts on Nasdaq with 68% Share Surge After $225 Million IPO

What's Happening? Windward Bio Group AG, a clinical-stage biotechnology company, commenced trading on the Nasdaq Global Select Market on November 13, 2026, under the ticker WWB. The company priced its initial public offering at $17.00 per share, selling approximately 10.29 million ordinary shares an
AI Generated
This may include content generated using AI tools. Glance teams are making active and commercially reasonable efforts to moderate all AI generated content. Glance moderation processes are improving however our processes are carried out on a best-effort basis and may not be exhaustive in nature. Glance encourage our users to consume the content judiciously and rely on their own research for accuracy of facts. Glance maintains that all AI generated content here is for entertainment purposes only.